Guardant Health Newsroom

Guardant Health Reports Revenue Growth Amid Cash Flow Losses

TipRanks05:48

Guardant Health | 8-K: Guardant Health Announces Preliminary Fourth Quarter and Full Year 2024 Results

SEC05:22 · Announcements

Craig-Hallum Maintains Guardant Health(GH.US) With Buy Rating

Futu NewsJan 13 22:31 · Ratings

Guardant Health (GH) Gets a Buy From Craig-Hallum

TipRanksJan 13 22:05 · Ratings

Guardant Health Announced Preliminary FY2024 Sales Of Approximately $737M, An Increase Of 31% Compared To Consensus Of $723.9M

BenzingaJan 13 20:09

Express News | Guardant Health Q4 Revenue USD 200 Million Vs. IBES Estimate USD 186.7 Million

BreakingsJan 13 20:00

Press Release: Guardant Health Announces Preliminary Fourth Quarter and Full Year 2024 Results

Dow JonesJan 13 20:00

Plug Power, Capri And Frontline Are Among Top Mid Cap Gainers Last Week (Jan 6-10): Are The Others In Your Portfolio?

BenzingaJan 12 22:47

UBS Maintains Guardant Health(GH.US) With Buy Rating, Maintains Target Price $40

Futu NewsJan 11 06:31 · Ratings

Guardant Health Holds 'Underappreciated' Catalyst Path, UBS Says

MT NewswiresJan 11 04:12

Bernstein Maintains Guardant Health(GH.US) With Buy Rating, Raises Target Price to $45

Futu NewsJan 11 02:31 · Ratings

Jefferies Maintains Guardant Health(GH.US) With Buy Rating, Maintains Target Price $42

Futu NewsJan 8 21:31 · Ratings

Jefferies Maintains Guardant Health(GH.US) With Buy Rating, Raises Target Price to $42

Futu NewsJan 8 07:31 · Ratings

Express News | Guardant Health Shield Platform Selected for Inclusion in National Cancer Institute’s Vanguard Study to Evaluate Emerging Technologies for Multi-Cancer Detection

BreakingsJan 7 21:03

Guardant Health Shield Platform Selected for Inclusion in National Cancer Institute's Vanguard Study to Evaluate Emerging Technologies for Multi-Cancer Detection

BusinesswireJan 7 21:03

Guardant Health (GH) Soars 6.3%: Is Further Upside Left in the Stock?

Zacks Jan 7 16:20

Piper Sandler Maintains Guardant Health(GH.US) With Buy Rating, Maintains Target Price $34

Futu NewsJan 4 00:31 · Ratings

Guardant Health to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

BusinesswireJan 3 05:05

Guardant Health (NASDAQ:GH Shareholders Incur Further Losses as Stock Declines 8.9% This Week, Taking Three-year Losses to 68%

Simply Wall StDec 22, 2024 20:42

Meaningful Insights Biotech Analytics (MiBA) and Guardant Health Announce Strategic Partnership to Optimize Use of Biomarker Testing and Data Analytics to Improve Cancer Care

BusinesswireDec 20, 2024 21:05